Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 14 Issue 1, January 2018

Potent small-molecule inhibitors of the endosomal Toll-like receptor TLR8 bind a unique site on the inactive dimer interface to stabilize the resting state. The representation of TLR8 dimeric complexes is based on X-ray crystallographic structures, with the computationally simulated protein surface in color. The compounds suppress TLR8-mediated proinflammatory signaling in cell lines, in human primary cells, and in tissue from rheumatoid arthritis and osteoarthritis patients, highlighting TLR8 inhibition as a potential therapeutic approach for these diseases. Cover art by Erin Dewalt, based on artwork created by Cuncun Zhao. Article, p58

Research Highlights

Top of page ⤴

News & Views

  • Modification of folded proteins at will, within any sequence context, remains an elusive goal. A proteome-wide screening approach has now identified a set of protein ligases that enables conjugation of peptides to almost any protein N terminus, overcoming longstanding limitations in protein engineering.

    • Christian F W Becker
    News & Views
  • Glycosylation of Notch receptors regulates ligand-induced Notch signaling, which is essential for normal development in animals. Fucose analogs targeting Notch glycosylation serve as ligand-specific Notch inhibitors and facilitate the understanding of how O-glycan regulates Notch–ligand interactions.

    • Tetsuya Okajima
    News & Views
Top of page ⤴

Brief Communication

Top of page ⤴

Article

Top of page ⤴

Search

Quick links